Salvadori Daniel Gesua Sive, EVP and Group President of Abbott Laboratories ($ABT), sold shares once on the open market in the last year for a total of $102 thousand. His most recent sale occurred on March 2, 2026. This places him in 9,544th position among 11,678 insiders by sale value, compared to an average of $8.6 million per insider across 6.37 transactions. He made no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | ABBOTT LABORATORIES | $ABT | Salvadori Daniel Gesua Sive | EVP AND GROUP PRESIDENT | S | Common shares without par value | 885 | $115.58 | 146,377.0000 | 1,996,795,525 | 0.60% | 0.00% |
| Feb. 27, 2026 | ABBOTT LABORATORIES | $ABT | Salvadori Daniel Gesua Sive | EVP AND GROUP PRESIDENT | F | Common shares without par value | 6615 | $116.26 | 147,262.0000 | 1,996,795,525 | 4.30% | 0.00% |
| Feb. 24, 2026 | ABBOTT LABORATORIES | $ABT | Salvadori Daniel Gesua Sive | EVP AND GROUP PRESIDENT | A | Option (right to buy) | 89226 | $0.00 | 89,226.0000 | 1,996,795,525 | 9999.99% | 0.00% |
| Feb. 24, 2026 | ABBOTT LABORATORIES | $ABT | Salvadori Daniel Gesua Sive | EVP AND GROUP PRESIDENT | A | Common shares without par value | 21644 | $0.00 | 153,877.0000 | 1,996,795,525 | 16.37% | 0.00% |
| Dec. 11, 2025 | ABBOTT LABORATORIES | $ABT | Salvadori Daniel Gesua Sive | EVP AND GROUP PRESIDENT | G | Common shares without par value | 1536 | $123.28 | 132,233.0000 | 1,996,743,794 | 1.15% | 0.00% |
| Feb. 28, 2025 | ABBOTT LABORATORIES | $ABT | Salvadori Daniel Gesua Sive | EVP AND GROUP PRESIDENT | F | Common shares without par value | 8462 | $135.87 | 133,769.0000 | 1,991,472,630 | 5.95% | 0.00% |
| Feb. 25, 2025 | ABBOTT LABORATORIES | $ABT | Salvadori Daniel Gesua Sive | EXECUTIVE VICE PRESIDENT | A | Common shares without par value | 16534 | $0.00 | 142,231.0000 | 1,991,472,630 | 13.15% | 0.00% |
| Feb. 25, 2025 | ABBOTT LABORATORIES | $ABT | Salvadori Daniel Gesua Sive | EXECUTIVE VICE PRESIDENT | A | Option (right to buy) | 61580 | $0.00 | 61,580.0000 | 1,991,472,630 | 9999.99% | 0.00% |
| Jan. 30, 2025 | ABBOTT LABORATORIES | $ABT | Salvadori Daniel Gesua Sive | EXECUTIVE VICE PRESIDENT | S | Common shares without par value | 23771 | $128.50 | 125,697.0000 | 1,991,472,630 | 15.90% | 0.00% |
| Jan. 30, 2025 | ABBOTT LABORATORIES | $ABT | Salvadori Daniel Gesua Sive | EXECUTIVE VICE PRESIDENT | M | Option (right to buy) | 23771 | $0.00 | 0.0000 | 1,991,472,630 | 100.00% | 0.00% |
| Jan. 30, 2025 | ABBOTT LABORATORIES | $ABT | Salvadori Daniel Gesua Sive | EXECUTIVE VICE PRESIDENT | M | Common shares without par value | 23771 | $38.40 | 149,468.0000 | 1,991,472,630 | 18.91% | 0.00% |
| Feb. 29, 2024 | ABBOTT LABORATORIES | $ABT | Salvadori Daniel Gesua Sive | EXECUTIVE VICE PRESIDENT | F | Common shares without par value | 8874 | $120.05 | 126,660.0000 | 1,987,883,852 | 6.55% | 0.00% |
| March 1, 2024 | ABBOTT LABORATORIES | $ABT | Salvadori Daniel Gesua Sive | EXECUTIVE VICE PRESIDENT | S | Common shares without par value | 963 | $118.50 | 125,697.0000 | 1,987,883,852 | 0.76% | 0.00% |
| Feb. 21, 2024 | ABBOTT LABORATORIES | $ABT | Salvadori Daniel Gesua Sive | EXECUTIVE VICE PRESIDENT | A | Option (right to buy) | 58898 | $0.00 | 58,898.0000 | 1,987,883,852 | 9999.99% | 0.00% |
| Feb. 21, 2024 | ABBOTT LABORATORIES | $ABT | Salvadori Daniel Gesua Sive | EXECUTIVE VICE PRESIDENT | A | Common shares without par value | 15673 | $0.00 | 135,534.0000 | 1,987,883,852 | 13.08% | 0.00% |
| March 1, 2023 | ABBOTT LABORATORIES | $ABT | Salvadori Daniel Gesua Sive | EXECUTIVE VICE PRESIDENT | S | Common shares without par value | 1085 | $100.70 | 119,861.0000 | 1,986,519,278 | 0.90% | 0.00% |
| Feb. 28, 2023 | ABBOTT LABORATORIES | $ABT | Salvadori Daniel Gesua Sive | EXECUTIVE VICE PRESIDENT | F | Common shares without par value | 9002 | $99.77 | 120,946.0000 | 1,986,519,278 | 6.93% | 0.00% |
| Feb. 17, 2023 | ABBOTT LABORATORIES | $ABT | Salvadori Daniel Gesua Sive | EXECUTIVE VICE PRESIDENT | A | Option (right to buy) | 69803 | $0.00 | 69,803.0000 | 1,986,519,278 | 9999.99% | 0.00% |
| Feb. 17, 2023 | ABBOTT LABORATORIES | $ABT | Salvadori Daniel Gesua Sive | EXECUTIVE VICE PRESIDENT | A | Common shares without par value | 17700 | $0.00 | 129,948.0000 | 1,986,519,278 | 15.77% | 0.00% |